Trials / Recruiting
RecruitingNCT07313527
PCR for Aspergillus Fumigatus in Blood and Bronchoalveolar Lavage Fluid for Monitoring Cases of Invasive Aspergillosis: What is Its Prognostic Value
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 100 (estimated)
- Sponsor
- University Hospital, Strasbourg, France · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Aspergillus fumigatus PCR is currently used in conjunction with serum galactomannan to support the diagnosis of invasive aspergillosis or for monitoring at-risk patients not receiving antifungal prophylaxis. A positive result and a high titer are thought to be associated with the advanced stage of the disease and the fungal load. However, there is limited data on this subject, and no study has primarily focused on the variation of PCR levels during treatment and its potential correlation with treatment efficacy.
Conditions
Timeline
- Start date
- 2025-03-17
- Primary completion
- 2026-02-01
- Completion
- 2026-02-01
- First posted
- 2026-01-02
- Last updated
- 2026-01-02
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT07313527. Inclusion in this directory is not an endorsement.